MoonLake Immunotherapeutics
MLTX· Nasdaq
Released Feb 26, 2025, before the open
10-K filed Feb 26, 2025, 57 days after period end · 0001821586-25-000006
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$45.61M | -$7.44M | -$11.86M | $34.51M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
MoonLake Immunotherapeutics · CIK 1821586 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2024 · filed Feb 26, 2025 · 57 d after period end
+4.0% from the close of Feb 25, 2025 to the close of Feb 26, 2025, the first after the release.